Abeona Therapeutics Inc (ABEO): Next-Year EPS Estimate 90.99%
As of 2026-06-04, Abeona Therapeutics Inc (ABEO) has a next-year EPS growth estimate of 90.99%.
On 2026-05-19, analyst consensus for ABEO's next-year EPS growth shifted from 120.20% to 90.99% — a negative change of 29.21 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at -171.45%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 90.99%
- EPS growth this year
- -171.45%
- EPS next quarter (est)
- -$0.22
- Last price
- $5.82
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 90.99% | -171.45% | -$0.22 | $5.82 |
| 2026-06-03 | 90.99% | -171.45% | -$0.22 | $5.67 |
| 2026-06-02 | 90.99% | -171.45% | -$0.22 | $5.69 |
| 2026-06-01 | 90.99% | -171.45% | -$0.22 | $5.63 |
| 2026-05-31 | 90.99% | -171.45% | -$0.22 | $5.78 |
| 2026-05-28 | 90.99% | -171.45% | -$0.22 | $5.78 |
| 2026-05-27 | 90.99% | -171.45% | -$0.22 | $5.69 |
| 2026-05-26 | 90.99% | -171.45% | -$0.22 | $5.49 |
| 2026-05-25 | 90.99% | -171.45% | -$0.22 | $5.44 |
| 2026-05-24 | 90.99% | -171.45% | -$0.22 | $5.44 |
| 2026-05-21 | 90.99% | -171.45% | -$0.22 | $5.52 |
| 2026-05-20 | 90.99% | -171.45% | -$0.22 | $5.32 |
| 2026-05-19 | 90.99% | -171.45% | -$0.22 | $5.12 |
| 2026-05-18 | 120.20% | -166.17% | -$0.20 | $5.37 |
| 2026-05-17 | 120.20% | -166.17% | -$0.20 | $5.49 |
| 2026-05-14 | 120.20% | -167.00% | -$0.21 | $5.60 |
| 2026-05-13 | 118.36% | -174.59% | -$0.21 | $5.68 |
| 2026-05-12 | 118.28% | -173.10% | -$0.34 | $5.68 |
| 2026-05-11 | 118.28% | -173.10% | -$0.34 | $5.86 |
| 2026-05-10 | 118.28% | -173.10% | -$0.34 | $5.90 |
| 2026-05-07 | 118.28% | -173.10% | -$0.34 | $5.77 |
| 2026-05-06 | 118.28% | -173.10% | -$0.34 | $6.01 |
| 2026-05-05 | 118.28% | -173.10% | -$0.34 | $5.83 |
| 2026-05-04 | 118.28% | -173.10% | -$0.34 | $5.95 |
| 2026-05-03 | 118.28% | -173.10% | -$0.34 | $5.43 |
| 2026-04-30 | 118.28% | -173.10% | -$0.34 | $5.46 |
| 2026-04-29 | 118.28% | -173.10% | -$0.34 | $5.34 |
| 2026-04-28 | 118.28% | -173.10% | -$0.34 | $5.36 |
| 2026-04-27 | 118.28% | -173.10% | -$0.34 | $5.34 |
| 2026-04-26 | 118.28% | -173.10% | -$0.34 | $5.39 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Abeona Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Abeona Therapeutics Inc (ABEO) has a next-year EPS growth estimate of 90.99%, based on analyst consensus.
When was the latest EPS estimate revision for ABEO?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 120.20% to 90.99%.
What sector and industry does Abeona Therapeutics Inc belong to?▾
Abeona Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ABEO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Abeona Therapeutics Inc (ABEO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports